SPOTLIGHT -
The Week in Review: March 18-22
From the relationship between glucose fluctuations and cognition in patients with type 1 diabetes to augmentation strategies for treatment-resistant depression, here are highlights from the week in Psychiatric Times.
COVID-19 Research Roundup: March 22, 2024
What is new in research on COVID-19?
First Patient Screened Ahead of Schedule in Phase 2 Clinical Trial of Therapeutic Candidate for Schizophrenia
The trial aims to investigate the positive, negative, and cognitive domains of schizophrenia.
Assessing, Treating, and Managing Spring Mania in Patients With Bipolar Disorder
What is spring mania, and what are some effective clinical strategies for addressing it?
The Week in Review: March 11-15
From mild cognitive impairment and serotonin system degeneration to an update on pimavanserin for negative symptoms of schizophrenia, here are highlights from the week in Psychiatric Times.
Child and Adolescent Psychiatry Research Roundup: March 15, 2024
What is new in research on child and adolescent psychiatry?
Mood Disorders in Psychiatric Times
Take a look back at our recent coverage relating to our March content theme.
The Week in Review: March 4-8
From an update on Prism for PTSD to the efficacy of home-use transcranial direct current stimulation for MDD, here are highlights from the week in Psychiatric Times.
Cannabis Research Roundup: March 8, 2024
What is new in research on cannabis?
Digital Cognitive Assessment Platform Secures $15 Million Investment
The screening tool includes multiple tests that assess memory, attention, executive function, reaction times, and motor function.
Study Highlights Efficacy of Prism for PTSD in Alleviating Chronic PTSD Symptoms
The therapy is the first self-neuromodulation device for PTSD approved by the US Food and Drug Administration.
First Participant Dosed in Phase 1b Trial of VLS-01 for TRD
This trial aims to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of VLS-01 compared with intravenous DMT for treatment-resistant depression.
The Week in Review: February 26-March 1
From personality disorders and common comorbidities to the effects of abortion bans on mental health, here are highlights from the week in Psychiatric Times.
ADHD Research Roundup: March 1, 2024
What is new in research on ADHD?
Presenting Our March Theme: Mood Disorders
Write to us now to be part of our series focused on mood disorders this month.
From the Pages of Psychiatric Times: February 2024
The experts weighed in on a wide variety of psychiatric issues for the February 2024 issue of Psychiatric Times.
Recap: Eating Disorders 2024
Here’s a look back at selections from our February content series on eating disorders.
Psychiatry in the News: February 2024
Here are some updates from the world of psychiatry throughout the month of February.
Eating Disorders and OTC Weight-Loss Product Consumption in Adolescents
Psychiatric Times discussed the recent research with Anne Marie O'Melia, MD, MS, FAAP, CEDS-S, of the Eating Recovery Center.
Eating Disorders in BIPOC Communities
Psychiatric Times sat down with Erikka D. Taylor, MD, MPH, DFAACAP, of Project HEAL to discuss the unique challenges associated with treatment of eating disorders in this patient population.
FDA Issues CRL for Roluperidone in the Treatment of Negative Symptoms of Schizophrenia
The CRL cited several areas for clinical improvement necessary for future approval of the treatment.
The Week in Review: February 19-23
From connections between bipolar disorder and cardiometabolic issues to management of agitation in emergency departments, here are highlights from the week in Psychiatric Times.
Eating Disorders Research Roundup: February 23, 2024
What is new in research on eating disorders?
Virginia Tech Carilion School of Medicine Announces Henrietta Lacks Excellence in Medicine Scholarship
Formerly known as the Dean’s Council Diversity Excellence in Medicine Endowed Scholarship, the scholarship will honor Henrietta Lacks’ contributions to science and medicine.
Expanded Partnerships to Increase Access to Telemental Health Coverage for Medicare, Medicaid Beneficiaries
These partnerships aim to address the mental health needs of underserved populations, including individuals with clinical depression, anxiety, and mood disorders.
Global Use of Nonprescription Weight-Loss Products Among Adolescents: 5 Key Takeaways
What does recent research tell us about use of nonprescription weight-loss products among teens?
The Week in Review: February 12-16
From psychotherapy vs pharmacotherapy for depression in heart failure to an update on the 2024 medication pipeline for antidepressants and ADHD treatments, here are highlights from the week in Psychiatric Times.
Schizophrenia Research Roundup: February 16, 2024
What is new in research on schizophrenia?
FDA Accepts, Grants Priority Review of NDA for MDMA-Assisted Therapy for PTSD
The treatment's PDUFA date is set for August 11, 2024.
Eating Disorders in Psychiatric Times
Take a look back at our recent coverage relating to our February content theme.